Ouro Fino Saúde Animal Participações Toekomstige groei
Future criteriumcontroles 4/6
De verwachting is dat Ouro Fino Saúde Animal Participações de winst en omzet met respectievelijk 39.4% en 14.8% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 39.2% per jaar.
Belangrijke informatie
39.4%
Groei van de winst
39.2%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 19.4% |
Inkomstengroei | 14.8% |
Toekomstig rendement op eigen vermogen | n/a |
Dekking van analisten | Low |
Laatst bijgewerkt | 09 Jul 2024 |
Recente toekomstige groei-updates
Recent updates
We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative
Aug 15One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts
May 19Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?
Dec 20These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well
Jul 28We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt
Feb 01Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet
May 27Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?
Mar 01Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?
Feb 08Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Jan 21Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?
Jan 03Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years
Dec 15Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?
Nov 27What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E
Aug 09We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt
Jul 13Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2025 | 1,197 | 112 | N/A | N/A | 1 |
12/31/2024 | 1,108 | 101 | N/A | N/A | 1 |
6/30/2024 | 940 | 54 | 105 | 153 | N/A |
3/31/2024 | 954 | -34 | 127 | 176 | N/A |
12/31/2023 | 943 | -50 | 143 | 190 | N/A |
9/30/2023 | 985 | -23 | 186 | 236 | N/A |
6/30/2023 | 1,002 | 17 | 123 | 181 | N/A |
3/31/2023 | 1,006 | 111 | 106 | 166 | N/A |
12/31/2022 | 1,041 | 131 | 20 | 90 | N/A |
9/30/2022 | 989 | 122 | -39 | 32 | N/A |
6/30/2022 | 943 | 112 | -1 | 65 | N/A |
3/31/2022 | 939 | 120 | -33 | 34 | N/A |
12/31/2021 | 905 | 114 | -20 | 47 | N/A |
9/30/2021 | 855 | 108 | 20 | 68 | N/A |
6/30/2021 | 845 | 119 | 32 | 69 | N/A |
3/31/2021 | 787 | 101 | 61 | 92 | N/A |
12/31/2020 | 730 | 90 | 87 | 112 | N/A |
9/30/2020 | 706 | 83 | 76 | 112 | N/A |
6/30/2020 | 635 | 50 | 33 | 77 | N/A |
3/31/2020 | 640 | 50 | 12 | 60 | N/A |
12/31/2019 | 620 | 46 | 4 | 56 | N/A |
9/30/2019 | 598 | 40 | 28 | 75 | N/A |
6/30/2019 | 604 | 50 | 29 | 80 | N/A |
3/31/2019 | 588 | 60 | 3 | 58 | N/A |
12/31/2018 | 589 | 69 | -5 | 43 | N/A |
9/30/2018 | 576 | 72 | -3 | 43 | N/A |
6/30/2018 | 546 | 60 | 10 | 46 | N/A |
3/31/2018 | 522 | 49 | N/A | 79 | N/A |
12/31/2017 | 505 | 38 | N/A | 100 | N/A |
9/30/2017 | 442 | 3 | N/A | 91 | N/A |
6/30/2017 | 437 | 0 | N/A | 82 | N/A |
3/31/2017 | 434 | -9 | N/A | 61 | N/A |
12/31/2016 | 457 | -5 | N/A | 42 | N/A |
9/30/2016 | 523 | 31 | N/A | 27 | N/A |
6/30/2016 | 547 | 44 | N/A | 34 | N/A |
3/31/2016 | 545 | 58 | N/A | 17 | N/A |
12/31/2015 | 534 | 69 | N/A | 16 | N/A |
9/30/2015 | 580 | 61 | N/A | 17 | N/A |
6/30/2015 | 459 | 50 | N/A | 13 | N/A |
3/31/2015 | 414 | 46 | N/A | 20 | N/A |
12/31/2014 | 402 | 43 | N/A | 5 | N/A |
12/31/2013 | 384 | 54 | N/A | 33 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei OFSA3 ( 39.4% per jaar) ligt boven de spaarquote ( 10.1% ).
Winst versus markt: De winst van OFSA3 ( 39.4% per jaar) zal naar verwachting sneller groeien dan de BR markt ( 13.3% per jaar).
Hoge groeiwinsten: De winst van OFSA3 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van OFSA3 ( 14.8% per jaar) zal naar verwachting sneller groeien dan de markt BR ( 7.6% per jaar).
Hoge groei-inkomsten: De omzet van OFSA3 ( 14.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van OFSA3 naar verwachting over 3 jaar hoog zal zijn